<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1160" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1160/" /><meta name="ncbi_pagename" content="Spastic Paraplegia 4 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spastic Paraplegia 4 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spastic Paraplegia 4" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/06/13" /><meta name="citation_author" content="Livia Parodi" /><meta name="citation_author" content="Siri Lynne Rydning" /><meta name="citation_author" content="Chantal Tallaksen" /><meta name="citation_author" content="Alexandra Durr" /><meta name="citation_pmid" content="20301339" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1160/" /><meta name="citation_keywords" content="SPAST-HSP" /><meta name="citation_keywords" content="SPG4" /><meta name="citation_keywords" content="SPG4" /><meta name="citation_keywords" content="SPAST-HSP" /><meta name="citation_keywords" content="Spastin" /><meta name="citation_keywords" content="SPAST" /><meta name="citation_keywords" content="Spastic Paraplegia 4" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spastic Paraplegia 4" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Livia Parodi" /><meta name="DC.Contributor" content="Siri Lynne Rydning" /><meta name="DC.Contributor" content="Chantal Tallaksen" /><meta name="DC.Contributor" content="Alexandra Durr" /><meta name="DC.Date" content="2019/06/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1160/" /><meta name="description" content="Spastic paraplegia 4 (SPG4; also known as SPAST-HSP) is characterized by insidiously progressive bilateral lower-limb gait spasticity. More than 50% of affected individuals have some weakness in the legs and impaired vibration sense at the ankles. Sphincter disturbances are very common. Onset is insidious, mostly in young adulthood, although symptoms may start as early as age one year and as late as age 76 years. Intrafamilial variation is considerable." /><meta name="og:title" content="Spastic Paraplegia 4" /><meta name="og:type" content="book" /><meta name="og:description" content="Spastic paraplegia 4 (SPG4; also known as SPAST-HSP) is characterized by insidiously progressive bilateral lower-limb gait spasticity. More than 50% of affected individuals have some weakness in the legs and impaired vibration sense at the ankles. Sphincter disturbances are very common. Onset is insidious, mostly in young adulthood, although symptoms may start as early as age one year and as late as age 76 years. Intrafamilial variation is considerable." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1160/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/spg4/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1160/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE889FC9E03F6AB1000000000A490390.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1160_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1160_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spg3a/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spg7/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1160_"><span class="title" itemprop="name">Spastic Paraplegia 4</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: <i>SPAST</i>-HSP, SPG4</div><p class="contrib-group"><span itemprop="author">Livia Parodi</span>, PhD, <span itemprop="author">Siri Lynne Rydning</span>, MD, <span itemprop="author">Chantal Tallaksen</span>, MD, PhD, and <span itemprop="author">Alexandra Durr</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1160_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1160_ai__"><div class="contrib half_rhythm"><span itemprop="author">Livia Parodi</span>, PhD<div class="affiliation small">Institut du Cerveau et de la Moelle Epini&#x000e8;re<br />Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale<br />Centre National de la Recherche Scientifique<br />Assistance Publique &#x02013; H&#x000f4;pitaux de Paris<br />Sorbonne Universit&#x000e9; &#x02013; Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re University Hospital<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.etutitsni-mci@idorap.aivil" class="oemail">gro.etutitsni-mci@idorap.aivil</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Siri Lynne Rydning</span>, MD<div class="affiliation small">Department of Neurology<br />Oslo University Hospital;<br />Institute of Clinical Medicine<br />University of Oslo<br />Oslo, Norway<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="on.oiu.nisidem@gnindyr.l.s" class="oemail">on.oiu.nisidem@gnindyr.l.s</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Chantal Tallaksen</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Oslo University Hospital<br />Oslo, Norway<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="on.oiu.nisidem@neskallat.latnahc" class="oemail">on.oiu.nisidem@neskallat.latnahc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alexandra Durr</span>, MD, PhD<div class="affiliation small">Institut du Cerveau et de la Moelle Epini&#x000e8;re<br />Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale<br />Centre National de la Recherche Scientifique<br />Assistance Publique &#x02013; H&#x000f4;pitaux de Paris<br />Sorbonne Universit&#x000e9; &#x02013; Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re University Hospital<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.etutitsni-mci@rrud.ardnaxela" class="oemail">gro.etutitsni-mci@rrud.ardnaxela</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 17, 2003</span>; Last Update: <span itemprop="dateModified">June 13, 2019</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="spg4.Summary" itemprop="description"><h2 id="_spg4_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spastic paraplegia 4 (SPG4; also known as <i>SPAST</i>-HSP) is characterized by insidiously progressive bilateral lower-limb gait spasticity. More than 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have some weakness in the legs and impaired vibration sense at the ankles. Sphincter disturbances are very common. Onset is insidious, mostly in young adulthood, although symptoms may start as early as age one year and as late as age 76 years. Intrafamilial variation is considerable.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SPAST</i>-HSP is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical features and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPAST</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Antispastic drugs for leg spasticity; anticholinergic antispasmodic drugs for urinary urgency; regular physiotherapy to stretch spastic muscles and prevent contractures. Consideration of botulinum toxin and intrathecal baclofen when oral drugs are ineffective and spasticity is severe and disabling. Urodynamic evaluation in order to initiate treatment when sphincter disturbances become a problem.</p><p><i>Surveillance:</i> Evaluation every 6-12 months to update medications and physical rehabilitation.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SPAST</i>-HSP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with age-related, nearly complete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and is characterized by significant intrafamilial clinical variability. Most individuals diagnosed with <i>SPAST</i>-HSP have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is low. Each child of an individual with <i>SPAST</i>-HSP has a 50% chance of inheriting the pathogenic variant. Prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if a pathogenic <i>SPAST</i> variant has been identified in an affected family member. Because of variable clinical expression, results of prenatal testing cannot be used to predict whether an individual will develop <i>SPAST</i>-HSP and, if so, what the age of onset, clinical course, and degree of disability will be.</p></div></div><div id="spg4.Diagnosis"><h2 id="_spg4_Diagnosis_">Diagnosis</h2><div id="spg4.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Spastic paraplegia 4 (SPG4; also known as <i>SPAST</i>-HSP) <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Characteristic clinical symptoms of insidiously progressive bilateral leg stiffness affecting gait with or without spasticity at rest and mild proximal weakness, often accompanied by urinary urgency</div></li><li class="half_rhythm"><div>Neurologic examination demonstrating corticospinal tract deficits affecting both legs (spastic weakness, hyperreflexia, and extensor plantar responses). Mildly impaired vibration sensation in the ankles is present in the majority of individuals.</div></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance, or exclusion of other causes of spastic paraplegia in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family)</div></li></ul><p>Note: The presence of other signs/symptoms suggestive of complicated hereditary spastic paraplegia does not exclude <i>SPAST</i>-HSP, although it reduces its probability.</p><p><b>Brain and spinal cord MRI</b></p><ul><li class="half_rhythm"><div>Often normal in individuals with <i>SPAST</i>-HSP</div></li><li class="half_rhythm"><div>Spinal cord atrophy can occur in <i>SPAST</i>-HSP, but is less pronounced than in other genetic causes of HSP.</div></li><li class="half_rhythm"><div>Mild vermis atrophy, a thin corpus callosum, subtle white matter changes, and/or cerebellar atrophy have been reported [<a class="bk_pop" href="#spg4.REF.duning.2010.1986">Duning et al 2010</a>, <a class="bk_pop" href="#spg4.REF.da_gra_a.2019.1117">da Gra&#x000e7;a et al 2019</a>].</div></li></ul><p>Note: The MRI is useful in identifying anomalies of the brain, cerebro-medullary junction, and medulla that are characteristic of disorders discussed in <a href="#spg4.Differential_Diagnosis">Differential Diagnosis</a>.</p><p><b>Electromyography (EMG)</b> with <b>nerve conduction velocities (NCV)</b> is used to exclude peripheral nervous system involvement, which could raise the possibility of an alternative diagnosis as severe polyneuropathy is not a frequent symptom of <i>SPAST</i>-HSP. Karle et al performed neurophysiologic examinations of 128 individuals with HSP, including 35 individuals with <i>SPAST</i>-HSP, and showed that massively elongated central motor conduction time argued against <i>SPAST</i>-HSP; however, reduced amplitudes and prolonged latencies were reported, in particular in individuals with a <i>SPAST</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant [<a class="bk_pop" href="#spg4.REF.karle.2013.158">Karle et al 2013</a>].</p></div><div id="spg4.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SPAST</i>-HSP <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a href="#spg4.Suggestive_Findings">Suggestive Findings</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPAST</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1160/table/spg4.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figspg4Tmoleculargenetictestingusedin" rid-ob="figobspg4Tmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: (1) Failure to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> does not absolutely exclude the diagnosis. (2) Once non-genetic causes have been excluded, testing for <i>SPAST</i>-HSP should be considered in <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., individuals with no family history of spasticity), as <i>SPAST</i> pathogenic variants can be identified in approximately 10%-20% of simplex cases [<a class="bk_pop" href="#spg4.REF.erichsen.2009a.1577">Erichsen et al 2009a</a>, <a class="bk_pop" href="#spg4.REF.shoukier.2009.187">Shoukier et al 2009</a>, <a class="bk_pop" href="#spg4.REF.fei.2011.1194">Fei et al 2011</a>].</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>SPAST</i>-HSP is broad, individuals with the distinctive findings described in <a href="#spg4.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#spg4.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with spastic paraplegia are more likely to be diagnosed using genomic testing (see <a href="#spg4.Option_2">Option 2</a>).</p><div id="spg4.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of <i>SPAST</i>-HSP, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SPAST</i> detects <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, as well as small intragenic deletions/insertions. The combination of <i>in silico</i> predictive algorithms and information retrieved from population databases is essential to establish the pathogenic role of variants of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> [<a class="bk_pop" href="#spg4.REF.richards.2015.405">Richards et al 2015</a>]. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found on <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SPAST</i> and other genes of interest (see <a href="#spg4.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder, a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1160/table/spg4.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figspg4Tmoleculargenetictestingusedin" rid-ob="figobspg4Tmoleculargenetictestingusedin">Table 1</a>).</div></li></ul><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="spg4.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by spastic paraplegia, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic &#x02013; and particularly when evidence supports <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance &#x02013; <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="spg4.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Spastic Paraplegia 4</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1160/table/spg4.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg4.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPAST</i></td><td headers="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75%-80%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_spg4.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%-25%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="spg4.TF.1.1"><p class="no_margin">See <a href="/books/NBK1160/#spg4.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="spg4.TF.1.2"><p class="no_margin">See <a href="#spg4.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="spg4.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="spg4.TF.1.4"><p class="no_margin">Benign variants can affect the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (see <a href="#spg4.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a> and <a href="#spg4.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>5. </dt><dd><div id="spg4.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="spg4.TF.1.6"><p class="no_margin">Exon and multiexon deletions and duplications account for approximately 20%-25% of <i>SPAST</i> pathogenic variants [<a class="bk_pop" href="#spg4.REF.beetz.2006.1926">Beetz et al 2006</a>, <a class="bk_pop" href="#spg4.REF.depienne.2007b.674">Depienne et al 2007b</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="spg4.Clinical_Characteristics"><h2 id="_spg4_Clinical_Characteristics_">Clinical Characteristics</h2><div id="spg4.Clinical_Description"><h3>Clinical Description</h3><p>The cardinal clinical feature of spastic paraplegia 4 (<i>SPAST</i>-HSP) is insidiously progressive bilateral lower-limb spasticity associated with brisk reflexes, ankle clonus, and bilateral extensor plantar responses. Sphincter disturbances are very frequent (77%), in particular urinary urgency and incontinence. Increased reflexes in the upper limbs may also occur (65%), but other symptoms and findings in the upper limbs are rare. A frequent additional feature is decreased, but not abolished, vibration sense at the ankles, occurring in 60% of individuals [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>]. Around 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have proximal weakness in the lower limbs [<a class="bk_pop" href="#spg4.REF.kanavin.2018.58">Kanavin &#x00026; Fjermestad 2018</a>, <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>, <a class="bk_pop" href="#spg4.REF.schneider.2019.207">Schneider et al 2019</a>].</p><p>Age at onset of symptoms ranges from infancy to the eighth decade. Age at onset is variable even among family members with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. A recent study including more than 500 individuals with <i>SPAST</i>-HSP confirmed that the age at onset is characterized by a bimodal distribution, with a major first peak before the first decade, and a second, lower one between the third and fifth decades. Penetrance is not complete; an estimated 6% of individuals remain asymptomatic throughout life. Penetrance is reported to be lower in females than in males [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>].</p><p>Disease severity generally worsens with the duration of the disease, although some individuals remain mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> all their lives. Disease severity is variable even among family members with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. After long disease duration (20 years), approximately 50% of individuals need assistance for walking, and approximately 10% require a wheelchair. Disease progression is more rapid in individuals with late onset (age &#x0003e;35 years) than in those with early onset [<a class="bk_pop" href="#spg4.REF.loureiro.2013.481">Loureiro et al 2013</a>, <a class="bk_pop" href="#spg4.REF.chrestian.2016.e122">Chrestian et al 2016</a>, <a class="bk_pop" href="#spg4.REF.polymeris.2016.1604">Polymeris et al 2016</a>, <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>].</p><p>Comparing men and women, <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al [2018]</a> observed that symptomatic females more often had increased upper-limb reflexes than males, representing a more severe and diffused disorder in women.</p><p>Leg spasms are frequent and may also develop before the onset of spasticity. Spasms are more frequent after physical activity, and tend to disappear when spasticity becomes more severe.</p><p>Bladder dysfunction remains one of the most frequent problems for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and may be more frequent in individuals with <i>SPAST</i>-HSP than in all individuals with HSP; <a class="bk_pop" href="#spg4.REF.schneider.2019.207">Schneider et al [2019]</a> reported urologic involvement in 91.2% of individuals with <i>SPAST</i>-HSP compared to 74.5% of individuals with HSP. The most frequent symptoms are urinary incontinence, hesitancy, increased frequency of micturition, and urgency. Incomplete bladder emptying may also occur [<a class="bk_pop" href="#spg4.REF.braschinsky.2010.263">Braschinsky et al 2010</a>]. The anal sphincter may also be affected, resulting in uncontrollable flatulence or fecal incontinence, affecting respectively 31.4% and 8.7% of individuals with HSP in one study [<a class="bk_pop" href="#spg4.REF.kanavin.2018.58">Kanavin &#x00026; Fjermestad 2018</a>]. In a study of urodynamic findings in 29 individuals with HSP, <a class="bk_pop" href="#spg4.REF.fourtassi.2012.558">Fourtassi et al [2012]</a> described signs of central neurogenic bladder in 82.7%, with detrusor overactivity in 52% and detrusor sphincter dyssynergia in 65.5%.</p><p><i>Pes cavus</i> and mild spastic dysarthria may be observed.</p><p>Subtle cognitive impairment has been documented [<a class="bk_pop" href="#spg4.REF.erichsen.2009b.124">Erichsen et al 2009b</a>]; but its relation to the disease remains undetermined. Cognitive deficits appear late in the disease course and are not present in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members of a given family. When detected by neuropsychological testing, the impairment is often subtle, limited to executive dysfunction, and without noticeable effect on daily living. No definite correlation with the type of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPAST</i> has been established.</p><p>Extensive neuropsychological assessment of nine adults with <i>SPAST</i>-HSP (including one asymptomatic individual) identified cognitive impairment fulfilling multidomain non-amnesic mild cognitive impairment criteria, with executive impairment and impaired social cognition [<a class="bk_pop" href="#spg4.REF.chamard.2016.6423461">Chamard et al 2016</a>] as suggested by <a class="bk_pop" href="#spg4.REF.tallaksen.2003.1113">Tallaksen et al [2003]</a>, where a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> aggregation of cognitive impairment suggested the implication of modifiers. In the large <i>SPAST</i>-HSP study by <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al [2018]</a>, intellectual disability was described in 4.2%.</p><p><b>Other findings</b> compatible with a complex form of HSP are uncommon in <i>SPAST</i>-HSP but do not exclude the diagnosis. Also, whether these additional findings are related to <i>SPAST</i>-HSP or coincidental remains to be clarified.</p><p>Neuropathy has been reported in individuals with <i>SPAST</i>-HSP, but without compelling evidence of a shared underlying pathologic mechanism. <a class="bk_pop" href="#spg4.REF.kumar.2012.1454">Kumar et al [2012]</a> found peripheral abnormalities in nerve conduction studies in two of 11 individuals with <i>SPAST</i>-HSP.</p><p>Non-motor symptoms are more frequent than previously acknowledged. <a class="bk_pop" href="#spg4.REF.servelhere.2016.408">Servelhere et al [2016]</a> studied 30 individuals and found that fatigue, pain, and depression were frequent and often severe manifestations in individuals with <i>SPAST-</i>HSP.</p><p>Restless legs syndrome has been associated with <i>SPAST</i>-HSP [<a class="bk_pop" href="#spg4.REF.sperfeld.2007.31">Sperfeld et al 2007</a>], but this remains to be confirmed.</p><p>Hand tremor was reported in 10% of a large cohort of Dutch individuals with <i>SPAST</i>-HSP [<a class="bk_pop" href="#spg4.REF.de_bot.2010.1073">de Bot et al 2010</a>].</p><p>Seizures, intellectual disability, and cerebellar ataxia are rare. A few individuals with severe dementia have been reported [<a class="bk_pop" href="#spg4.REF.murphy.2009.378">Murphy et al 2009</a>]. However, too few neuropathologic studies have been performed in persons with <i>SPAST</i>-HSP for a general picture of the distribution of cortical and medullar lesions in the disease to emerge.</p><p><b>Neuroimaging.</b> Newer MRI studies using advanced neuroimaging techniques have shown widespread involvement of gray and white matter in individuals with <i>SPAST</i>-HSP [<a class="bk_pop" href="#spg4.REF.lindig.2015.1961">Lindig et al 2015</a>, <a class="bk_pop" href="#spg4.REF.rezende.2015.e0117666">Rezende et al 2015</a>, <a class="bk_pop" href="#spg4.REF.liao.2018.1">Liao et al 2018</a>, <a class="bk_pop" href="#spg4.REF.rucco.2019.979">Rucco et al 2019</a>]. In a study of 11 individuals, fractional anisotropy was reduced in the corticospinal tracts, cingulate gyri, and splenium of the corpus callosum [<a class="bk_pop" href="#spg4.REF.rezende.2015.e0117666">Rezende et al 2015</a>]. Resting-state fMRI studies in 12 individuals with <i>SPAST</i>-HSP showed abnormal functional activity in several brain areas [<a class="bk_pop" href="#spg4.REF.liao.2018.1">Liao et al 2018</a>]. <a class="bk_pop" href="#spg4.REF.rucco.2019.979">Rucco et al [2019]</a> performed magnetoencephalography of ten individuals with <i>SPAST</i>-HSP and described global network rearrangements. Using diffusion tensor imaging and tract-based special statistics, <a class="bk_pop" href="#spg4.REF.lindig.2015.1961">Lindig et al [2015]</a> found that imaging findings in the 15 included individuals correlated with disease duration and severity.</p></div><div id="spg4.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Recently, after analyzing a cohort of more than 500 individuals with <i>SPAST</i>-HSP, <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al [2018]</a> showed that <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants were associated with an earlier age of onset (by 10 years), when compared to truncating variants. This finding provides an explanation for the bimodal age of onset distribution typical of <i>SPAST</i>-HSP.</p><p>It is important to note that age at onset and clinical severity are highly variable for a given variant, even in the same family. The observed difference in age of onset between related individuals ranged from 27 years to 69 years [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>]. Furthermore, two family members with the same variant can have in one case a pure spastic paraparesis and in the other a complex disease. For example, <a class="bk_pop" href="#spg4.REF.orlacchio.2004.849">Orlacchio et al [2004]</a> reported wide phenotypic variability with the p.Asn386Ser variant, with some individuals presenting with intellectual disability and others showing brain MRI abnormalities including thin corpus callosum or cerebellar atrophy.</p><p>The most plausible explanation for intra and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> is the presence of genetic modifiers. <a class="bk_pop" href="#spg4.REF.svenson.2004.157">Svenson et al [2004]</a> reported two rare nonsynonymous <i>SPAST</i> variants, c.131C&#x0003e;T (p.Ser44Leu) and c.134C&#x0003e;A (p.Pro45Gln) acting as age-of-onset modifiers. In several analyzed families, the individuals who had a <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and either a <a class="figpopup" href="/books/NBK1160/table/spg4.T.notable_spast_variants/?report=objectonly" target="object" rid-figpopup="figspg4Tnotablespastvariants" rid-ob="figobspg4Tnotablespastvariants">c.131C&#x0003e;T</a> or <a class="figpopup" href="/books/NBK1160/table/spg4.T.notable_spast_variants/?report=objectonly" target="object" rid-figpopup="figspg4Tnotablespastvariants" rid-ob="figobspg4Tnotablespastvariants">c.134C&#x0003e;A</a> variant on the other allele (<i>in trans</i>) had a very early onset, suggesting that these alleles could modify the HSP <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#spg4.REF.svenson.2004.157">Svenson et al 2004</a>, <a class="bk_pop" href="#spg4.REF.mcdermott.2006.45">McDermott et al 2006</a>, personal communication]. The <i>SPAST</i> variant c.131C&#x0003e;T has a frequency of 0.4% in a control population, c.134C&#x0003e;A is even more rare in the <a href="https://gnomad.broadinstitute.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">gnomAD Database</a> [<a class="bk_pop" href="#spg4.REF.karczewski.2019">Karczewski et al 2019</a>]. In addition to the two <i>SPAST</i> variants, an <i>HSPD1</i> variant was proposed as a <i>SPAST</i>-HSP age-at-onset modifier [<a class="bk_pop" href="#spg4.REF.svenstrup.2009.90">Svenstrup et al 2009</a>], but its role remains under discussion.</p></div><div id="spg4.Penetrance"><h3>Penetrance</h3><p>Penetrance is age dependent and mostly complete in individuals with <i>SPAST</i>-HSP. It is estimated to be 85% by age 45 years [<a class="bk_pop" href="#spg4.REF.fonknechten.2000.637">Fonknechten et al 2000</a>] and complete at 70 years [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>]. It should be emphasized that age dependence is explained partly by variability in age at onset and partly by the difficulty in determining the precise age of onset; thus, neurologic examination is important. Penetrance is greater if pyramidal signs as well as spastic gait are considered: approximately 6% of individuals who have a <i>SPAST</i> variant are completely asymptomatic on examination; approximately 20% have abnormal signs when examined, but no awareness of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Penetrance may be gender dependent. <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al [2018]</a> reported a higher <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in males (94%) than females (88%), and greater gender discordance in individuals with onset before the third decade (91% vs 70%).</p></div><div id="spg4.Nomenclature"><h3>Nomenclature</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is responsible for spastic paraplegia at the SPG4 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, <i>SPAST</i>, was previously known as <i>SPG4.</i></p><p><i>SPAST</i>-HSP may also be referred to as SPG4. Previously it was also known as hereditary spastic paraplegia, spastin type [<a class="bk_pop" href="#spg4.REF.marras.2016.436">Marras et al 2016</a>].</p></div><div id="spg4.Prevalence"><h3>Prevalence</h3><p>The most recent epidemiologic study estimates a global prevalence of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>-HSP (AD-HSP) of 1-5:100,000 [<a class="bk_pop" href="#spg4.REF.ruano.2014.174">Ruano et al 2014</a>].</p><p>Among AD-HSPs, <i>SPAST</i> is the most frequently associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in both <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases [<a class="bk_pop" href="#spg4.REF.lo_giudice.2014.518">Lo Giudice et al 2014</a>, <a class="bk_pop" href="#spg4.REF.ruano.2014.174">Ruano et al 2014</a>]. Reports from many European countries as well as the US, Canada, Japan, and China appear to indicate that <i>SPAST</i>-HSP accounts for 40% of inherited AD-HSPs and 20% of simplex HSPs [<a class="bk_pop" href="#spg4.REF.erichsen.2009a.1577">Erichsen et al 2009a</a>, <a class="bk_pop" href="#spg4.REF.takiyama.2010.931">Takiyama et al 2010</a>, <a class="bk_pop" href="#spg4.REF.fei.2011.1194">Fei et al 2011</a>, <a class="bk_pop" href="#spg4.REF.lo_giudice.2014.518">Lo Giudice et al 2014</a>, <a class="bk_pop" href="#spg4.REF.ruano.2014.174">Ruano et al 2014</a>].</p><p>Geographic prevalence may vary; <a class="bk_pop" href="#spg4.REF.meijer.2002.763">Meijer et al [2002]</a> found fewer families with <i>SPAST</i>-HSP among North American families than expected from reports in European families.</p></div></div><div id="spg4.Genetically_Related_Allelic_Disorde"><h2 id="_spg4_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>Some individuals with a <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have lower motor neuron degeneration, leading to an ALS-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#spg4.REF.meyer.2005.141">Meyer et al 2005</a>, <a class="bk_pop" href="#spg4.REF.parodi.2017.352">Parodi et al 2017</a>].</p></div><div id="spg4.Differential_Diagnosis"><h2 id="_spg4_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a> for a review of the differential diagnosis.</p><p><i>SPAST</i>-HSP is the most frequently occurring form of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hereditary spastic paraplegia, accounting for an estimated 40% of AD-HSP [<a class="bk_pop" href="#spg4.REF.lo_giudice.2014.518">Lo Giudice et al 2014</a>]. Because <i>SPAST</i> is the most commonly involved <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in AD-HSP, it is the first and most relevant gene to be tested. The other main types of autosomal dominant pure spastic paraplegia to consider are SPG3A, SPG31, and SPG10.</p><p>With the exceptions of <a href="/books/n/gene/spg3a/">SPG3A</a>, SPG31, and SPG10, no significant differences have been established between SPG4 and other types of pure dominant spastic paraplegia.</p><div id="spg4.T.other_types_of_autosomal_dominant" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Types of Autosomal Dominant Pure Spastic Paraplegia (AD-HSP) to Consider in the Differential Diagnosis of <i>SPAST</i>-HSP</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1160/table/spg4.T.other_types_of_autosomal_dominant/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg4.T.other_types_of_autosomal_dominant_lrgtbl__"><table><thead><tr><th id="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features Distinguishing the Disorder from <i>SPAST</i>-HSP</th></tr></thead><tbody><tr><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATL1</i></td><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/spg3a/">SPG3A</a></td><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Earlier onset (often age &#x0003c;10 yrs)</div></li><li class="half_rhythm"><div>More muscle wasting in lower limbs &#x00026; scoliosis</div></li><li class="half_rhythm"><div>Fewer sphincter disturbances</div></li><li class="half_rhythm"><div>Less frequent impairment of vibration sense at the ankles &#x00026; &#x02191; reflexes in upper limbs</div></li><li class="half_rhythm"><div>2nd most common type of AD-HSP</div></li></ul>
</td></tr><tr><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KIF5A</i></td><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG10<br />(OMIM <a href="http://omim.org/entry/604187" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604187</a>)</td><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">More frequent peripheral neuropathy, amyotrophy, or parkinsonism</td></tr><tr><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>REEP1</i></td><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SPG31<br />(OMIM <a href="http://omim.org/entry/610250" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610250</a>)</td><td headers="hd_h_spg4.T.other_types_of_autosomal_dominant_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>More frequent peripheral neuropathy or amyotrophy</div></li><li class="half_rhythm"><div>3rd most common type of AD-HSP</div></li></ul>
</td></tr></tbody></table></div></div><p>In <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., spasticity in one individual in a family), all possible causes of spasticity in the legs must be considered because several non-genetic causes of spasticity are more common than <i>SPAST</i>-HSP.</p></div><div id="spg4.Management"><h2 id="_spg4_Management_">Management</h2><div id="spg4.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with spastic paraplegia 4 (<i>SPAST</i>-HSP), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Neuro-urologic examination is advised for individuals who have sphincter disturbances.</div></li><li class="half_rhythm"><div>Whether neuropsychological testing should be performed to assess the cognitive impairment frequently reported in individuals with <i>SPAST</i>-HSP remains unclear. So far, no consensus exists on the type of tests that should be performed, or on the timing or purpose of the tests. Considering that cognitive impairment is often absent or is detectable only by neuropsychological testing, one should be wary of increasing the burden of individuals with <i>SPAST</i>-HSP, and probably only recommend further testing when required by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual.</div></li><li class="half_rhythm"><div>Electrophysiologic investigations may be advisable in case of pain and/or edema in the lower limbs to evaluate for associated neuropathy. Neuropathy, while not a feature of <i>SPAST</i>-HSP per se, may occur in individuals with <i>SPAST</i>-HSP for other reasons and should be investigated and adequately treated. Because of the underlying HSP, the neuropathy may remain undiagnosed if routine investigations are not conducted.</div></li><li class="half_rhythm"><div>Spinal MRI examination to exclude any additional degenerative disorder can be considered if unusual symptoms or pain are present.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor is appropriate.</div></li></ul></div><div id="spg4.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic as there is still no curative or disease-modifying treatment for <i>SPAST</i>-HSP. Care by a multidisciplinary team that includes a general practitioner, neurologist, clinical geneticist, physiotherapist, physical therapist, social worker, and psychologist should be considered.</p><p>Symptomatic treatment includes use of the following:</p><ul><li class="half_rhythm"><div>Antispastic drugs for leg spasticity</div></li><li class="half_rhythm"><div>Anticholinergic antispasmodic drugs for urinary urgency</div></li><li class="half_rhythm"><div>Regular physiotherapy for stretching of spastic muscles. Stretching should be done manually at all levels (hips, knees, ankles) and preceded by heat conditioning. Early regular physiotherapy can prevent contractures to a certain extent. Intensive and early physiotherapy delays the development of symptoms related to spasticity and prolongs the ability to walk [Author, personal observation]. To date, the effectiveness of physical therapy in individuals with HSP is only documented in a small number of case reports and uncontrolled studies.</div></li></ul><p>Botulinum toxin and intrathecal baclofen can be proposed when oral drugs are ineffective and spasticity is severe and disabling. In children, orthopedic treatment and botulinum toxin injections may also contribute to better ambulatory function. A recent study of a mixed cohort of 33 individuals with HSP suggested that botulinum toxin-A injections provide some benefits, not only for spasticity, but also for fatigue [<a class="bk_pop" href="#spg4.REF.servelhere.2018.183">Servelhere et al 2018</a>]. However, studies are scarce and more systematic studies are needed to confirm these observations.</p><p>Urodynamic evaluation should be performed early in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals complaining of urgency or other problems, such as voiding difficulties, urine retention, and/or frequent urinary infections. Such symptoms should be monitored and treated according to individual needs and disease evolution. Follow up of the sphincter disturbances is important to prevent bladder dysfunction. Treatment options include anticholinergic drugs and intravesical botulinum-toxin injections [<a class="bk_pop" href="#spg4.REF.joussain.2019.1081">Joussain et al 2019</a>].</p></div><div id="spg4.Surveillance"><h3>Surveillance</h3><p>Specialized outpatient evaluations are suggested every six to 12 months to update medications and physical rehabilitation.</p></div><div id="spg4.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#spg4.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="spg4.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="spg4.Other"><h3>Other</h3><p>A double-blind crossover trial with gabapentin did not show improvement of spasticity in persons with <i>SPAST</i>-HSP [<a class="bk_pop" href="#spg4.REF.scheuer.2007.663">Scheuer et al 2007</a>].</p></div></div><div id="spg4.Genetic_Counseling"><h2 id="_spg4_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="spg4.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spastic paraplegia 4 (<i>SPAST</i>-HSP) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="spg4.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals diagnosed with <i>SPAST</i>-HSP usually have a symptomatic parent who has the <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, a parent with the <i>SPAST</i> pathogenic variant may have no symptoms.</div></li><li class="half_rhythm"><div>An individual with <i>SPAST</i>-HSP may, more rarely, have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include neurologic examination for evidence of spasticity and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if a <i>SPAST</i> pathogenic variant has been identified in a family member.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of a proband inheriting a pathogenic variant from a parent with germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>SPAST</i>-HSP may appear to be negative because of failure to recognize the disorder in family members, reduced (age-related) <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or early death of the parent before the onset of symptoms. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the clinical/genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. Note: Significant <a class="def" href="/books/n/gene/glossary/def-item/intrafamilial-variability/">intrafamilial variability</a> in age of onset and clinical severity is observed in <i>SPAST</i>-HSP.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#spg4.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are clinically unaffected but have not undergone <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, sibs of the proband are still presumed to be at increased risk for <i>SPAST</i>-HSP because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>SPAST</i>-HSP has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the <i>SPAST</i> variant present in the affected family member, his or her family members are at risk.</p></div><div id="spg4.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once a <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including, but not limited to, socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of at-risk individuals age &#x0003c;18 years)</b></p><ul><li class="half_rhythm"><div>For asymptomatic minors at risk for typically adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>policy statement</u></a>: ethical and policy issues in genetic testing and screening of children.</div></li><li class="half_rhythm"><div>In a family with an established diagnosis of <i>SPAST</i>-HSP, it is appropriate to consider testing of symptomatic individuals regardless of age.</div></li></ul><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="spg4.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once a <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible. Because of variable clinical expression, the results of prenatal testing cannot be used to predict whether an individual will develop <i>SPAST</i>-HSP and, if so, what the age of onset, clinical course, or degree of disability will be.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="spg4.Resources"><h2 id="_spg4_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>EURO HSP</b></div><div>Plateforme Maladies Rares</div><div>99 Rue Didot</div><div>Paris 75014</div><div>France</div><div><b>Phone:</b> 33 1 56 53 52 61</div><div><b>Email:</b> president@eurohsp.eu</div><div><a href="http://www.eurohsp.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.eurohsp.eu</a></div></li><li class="half_rhythm"><div><b>HSP Research Foundation</b></div><div>P.O. Box 4064</div><div>Warrimoo New South Wales NSW 2774</div><div>Australia</div><div><a href="https://www.hspersunite.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hspersunite.org.au</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li><li class="half_rhythm"><div><b>Tom Wahlig-Foundation</b></div><div>Tom Wahlig Stiftung</div><div>B&#x000fc;ro Veghestrasse 22</div><div>Germany</div><div><b>Phone:</b> 49 (0) 251 - 20 07 91 20</div><div><b>Email:</b> nfo@hsp-info.de</div><div><a href="http://www.hsp-info.de/en/foundation.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hsp-info.de/en/foundation.htm</a></div></li><li class="half_rhythm"><div><b>A.I. Vi.P.S.</b></div><div>Associazione Italiana Vivere la Paraparesi Spastica Onlus</div><div>Via Tevere, 7</div><div>20020 Lainate (MI)</div><div>Italy</div><div><b>Phone:</b> 39 392 9825622</div><div><b>Email:</b> nfo@vipsonlus.it</div><div><a href="http://www.vipsonlus.it/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.vipsonlus.it</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Norsk forening for Arvelig-Spastisk Paraparese / Ataksi (NASPA)</b></div><div><i>The Norwegian association for individuals with hereditary spastic paraplegia and ataxia</i></div><div>PO Box 9217</div><div>Oslo 0134</div><div>Norway</div><div><b>Phone:</b> 47 24 10 24 00</div><div><b>Fax:</b> 47 24 10 24 99</div><div><b>Email:</b> naspa@nhf.no</div><div><a href="http://www.naspa.no" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.naspa.no</a></div></li></ul></div><div id="spg4.Molecular_Genetics"><h2 id="_spg4_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="spg4.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spastic Paraplegia 4: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1160/table/spg4.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg4.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_spg4.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_spg4.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_spg4.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_spg4.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_spg4.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_spg4.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_spg4.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6683" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SPAST</i></a></td><td headers="hd_b_spg4.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6683" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_spg4.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UBP0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spastin</a></td><td headers="hd_b_spg4.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SPAST" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPAST database</a><br /><a href="https://gwas.biosciencedbc.jp/cgi-bin/hvdb/hv_pos.cgi?gid=EG6683&#x00026;gchk=0&#x00026;vchk=0&#x00026;pchk=0&#x00026;nchk=0&#x00026;cchk=0&#x00026;lchk=0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Human Variation Database - SPAST</a></td><td headers="hd_b_spg4.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPAST" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPAST</a></td><td headers="hd_b_spg4.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SPAST[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPAST</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="spg4.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="spg4.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spastic Paraplegia 4 (<a href="/omim/182601,604277" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1160/table/spg4.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg4.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/182601" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">182601</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604277" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604277</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIN; SPAST</td></tr></tbody></table></div></div><div id="spg4.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b>
<i>SPAST</i> encodes a 616-amino acid protein named spastin, a putative nuclear member of the AAA (ATPases associated with diverse cellular activities). <a class="bk_pop" href="#spg4.REF.claudiani.2005.358">Claudiani et al [2005]</a> have shown that two spastin <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> &#x02013; M1 and M87, of 68 kd and 60 kd, respectively &#x02013; were synthesized from the <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> through usage of two different translational start sites. Spastin-M87 was detected in both spinal cord and cerebral cortex, whereas appreciable levels of spastin-M1 were observed only in spinal cord [<a class="bk_pop" href="#spg4.REF.solowska.2010.2767">Solowska et al 2010</a>].</p><p>Spastin is widely expressed in the neurons of the central nervous system, including the cortex and striatum. Distal degeneration of long tracts in the spinal cord is associated with a microglial reaction [<a class="bk_pop" href="#spg4.REF.wharton.2003.1166">Wharton et al 2003</a>]. In addition, the presence of a large number of thin axons in the pyramidal tracts may suggest the existence of a regeneration process [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>]. Tau-pathology outside the motor system may also be observed [<a class="bk_pop" href="#spg4.REF.wharton.2003.1166">Wharton et al 2003</a>] but is not common to all the analyzed cases [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>].</p><p>Within the cells, spastin acts as a microtubule-severing protein and is responsible for different aspects of microtubule dynamics, such as their length, number, and mobility [<a class="bk_pop" href="#spg4.REF.errico.2002.153">Errico et al 2002</a>]. Four proteic domains allow spastin to accomplish its enzymatic function, as well as to interact with other proteins.</p><ul><li class="half_rhythm"><div>Spastin N-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is involved in both lipid metabolism [<a class="bk_pop" href="#spg4.REF.papadopoulos.2015.e1005149">Papadopoulos et al 2015</a>] and endoplasmic reticulum morphogenesis, after interacting with ATL1/SPG3A and REEP1/SPG31 [<a class="bk_pop" href="#spg4.REF.park.2010.1097">Park et al 2010</a>].</div></li><li class="half_rhythm"><div>The microtubule-interacting and trafficking <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (MIT) allows spastin to interact with CHIMP1 and IST1, two proteins belonging to the endosomal-sorting complex required for transport (ESCRT-III), being therefore involved in both cytokinesis and endosomal-tubule recycling [<a class="bk_pop" href="#spg4.REF.reid.2005.19">Reid et al 2005</a>, <a class="bk_pop" href="#spg4.REF.connell.2009.42">Connell et al 2009</a>, <a class="bk_pop" href="#spg4.REF.allison.2013.527">Allison et al 2013</a>].</div></li><li class="half_rhythm"><div>The microtubule-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (MTBD) and the AAA ATPase cassette are responsible for the microtubule binding and ATP hydrolysis [<a class="bk_pop" href="#spg4.REF.white.2007.995">White et al 2007</a>].</div></li></ul><p><b>Mechanism of disease causation.</b> Spastin loss of function, and consequent <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>, has been proposed as the mechanism of disease causation: the majority of <i>SPAST</i> pathogenic variants affect the AAA cassette <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and almost 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals were found to have large deletions [<a class="bk_pop" href="#spg4.REF.depienne.2007a.281">Depienne et al 2007a</a>, <a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>]. In addition, reduced spastin <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> was observed in individuals with premature protein termination [<a class="bk_pop" href="#spg4.REF.b_rger.2000.771">B&#x000fc;rger et al 2000</a>].</p><p>An alternative to the <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> model, the finding that <i>SPAST</i> pathogenic variants in the AAA <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> led to constitutive binding to microtubules, could suggest a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect [<a class="bk_pop" href="#spg4.REF.errico.2002.153">Errico et al 2002</a>]. The abnormal spastin-microtubule interaction was observed leading to organelle transport impairments, possibly underlying degeneration of the corticospinal axons [<a class="bk_pop" href="#spg4.REF.mcdermott.2003.748">McDermott et al 2003</a>].</p><p>An additional alternative hypothesis was recently proposed by <a class="bk_pop" href="#spg4.REF.solowska.2010.2767">Solowska et al [2010]</a> and <a class="bk_pop" href="#spg4.REF.solowska.2014.1856">Solowska et al [2014]</a>. After observing that some of the <i>SPAST</i> pathogenic variants located outside the AAA cassette may act through another pathogenic mechanism, they generated a mouse model overexpressing human spastin and carrying a <i>SPAST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Adult <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> mice presented with spastic-like tremors and gait impairments as well as decreased microtubule stability, leading the researchers to conclude in favor of a gain (rather than loss) -of-function mechanism [<a class="bk_pop" href="#spg4.REF.qiang.2019.1136">Qiang et al 2019</a>].</p><p>In conclusion, the debate concerning <i>SPAST</i>-HSP pathogenic mechanism remains open. It must be emphasized that the <i>SPAST</i> mutation spectrum, which mostly includes pathogenic variants introducing premature termination codons and therefore leading to degradation of the <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> by <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay, argues in favor of <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> (i.e., disease occurs once the level of functional spastin falls below a critical level), rather than a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect [<a class="bk_pop" href="#spg4.REF.patrono.2002.200">Patrono et al 2002</a>, <a class="bk_pop" href="#spg4.REF.schickel.2007.1322">Schickel et al 2007</a>]. The recent observation that <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants are associated with earlier onset [<a class="bk_pop" href="#spg4.REF.parodi.2018.3331">Parodi et al 2018</a>] may suggest, in specific cases, the existence of pathogenic mechanisms other than haploinsufficiency.</p><p><b><i>SPAST</i>-specific laboratory considerations.</b>
<i>SPAST</i> undergoes alternate <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> with variable inclusion of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4. No pathogenic variants have been reported in exon 4, however, suggesting that the isoform lacking exon 4 is the predominant functional form of spastin in the adult nervous system. This transcript variant is <a href="/nuccore/NM_199436.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_199436.1</a> (see <a href="/books/NBK1160/#spg4.molgen.TA">Table A</a>, <b>Gene</b>).</p><p>Both <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>/multiexon deletions and duplications may be pathogenic <i>SPAST</i> variants.</p><div id="spg4.T.notable_spast_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Notable <i>SPAST</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1160/table/spg4.T.notable_spast_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg4.T.notable_spast_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg4.T.notable_spast_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_spg4.T.notable_spast_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_spg4.T.notable_spast_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_spg4.T.notable_spast_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_014946.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014946<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?val=NP_055761.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055761<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.131C&#x0003e;T</td><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser44Leu</td><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Earlier disorder onset, more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#spg4.REF.svenson.2004.157">Svenson et al 2004</a>, <a class="bk_pop" href="#spg4.REF.mcdermott.2006.45">McDermott et al 2006</a>]</td></tr><tr><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.134C&#x0003e;A</td><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro45Gln</td><td headers="hd_h_spg4.T.notable_spast_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Earlier disorder onset, more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#spg4.REF.svenson.2004.157">Svenson et al 2004</a>, <a class="bk_pop" href="#spg4.REF.mcdermott.2006.45">McDermott et al 2006</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div></div><div id="spg4.References"><h2 id="_spg4_References_">References</h2><div id="spg4.Published_Guidelines__Consensus_Sta"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="spg4.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 6-6-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 6-6-19.</div></li></ul></div><div id="spg4.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.allison.2013.527">Allison R, Lumb JH, Fassier C, Connell JW, Ten Martin D, Seaman MN, Hazan J, Reid E. An ESCRT-spastin interaction promotes fission of recycling tubules from the endosome. <span><span class="ref-journal">J Cell Biol. </span>2013;<span class="ref-vol">202</span>:527–43.</span> [<a href="/pmc/articles/PMC3734076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3734076</span></a>] [<a href="/pubmed/23897888" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23897888</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.beetz.2006.1926">Beetz C, Nygren AO, Schickel J, Auer-Grumbach M, B&#x000fc;rk K, Heide G, Kassubek J, Klimpe S, Klopstock T, Kreuz F, Otto S, Sch&#x000fc;le R, Sch&#x000f6;ls L, Sperfeld AD, Witte OW, Deufel T. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1926–30.</span> [<a href="/pubmed/17035675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17035675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.braschinsky.2010.263">Braschinsky M, Zopp I, Kals M, Haldre S, Gross-Paju K. Bladder dysfunction in hereditary spastic paraplegia: what to expect? <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2010;<span class="ref-vol">81</span>:263–6.</span> [<a href="/pubmed/19726407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19726407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.b_rger.2000.771">B&#x000fc;rger J, Fonknechten N, Hoeltzenbein M, Neumann L, Bratanoff E, Hazan J, Reis A. Hereditary spastic paraplegia caused by mutations in the SPG4 gene. <span><span class="ref-journal">Eur J Hum Genet. </span>2000;<span class="ref-vol">8</span>:771–6.</span> [<a href="/pubmed/11039577" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11039577</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.chamard.2016.6423461">Chamard L, Ferreira S, Pijoff A, Silvestre M, Berger E, Magnin E. Cognitive impairment involving social cognition in SPG4 hereditary spastic paraplegia. <span><span class="ref-journal">Behav Neurol. </span>2016;<span class="ref-vol">2016</span>:6423461.</span> [<a href="/pmc/articles/PMC5027053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5027053</span></a>] [<a href="/pubmed/27688599" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27688599</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.chrestian.2016.e122">Chrestian N, Dupr&#x000e9; N, Gan-Or Z, Szuto A, Chen S, Venkitachalam A, Brisson JD, Warman-Chardon J, Ahmed S, Ashtiani S, MacDonald H, Mohsin N, Mourabit-Amari K, Provencher P, Boycott KM, Stavropoulos DJ, Dion PA, Ray PN, Suchowersky O, Rouleau GA, Yoon G. Clinical and genetic study of hereditary spastic paraplegia in Canada. <span><span class="ref-journal">Neurol Genet. </span>2016;<span class="ref-vol">3</span>:e122.</span> [<a href="/pmc/articles/PMC5141523/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5141523</span></a>] [<a href="/pubmed/27957547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27957547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.claudiani.2005.358">Claudiani P, Riano E, Errico A, Andolfi G, Rugarli EI. Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus. <span><span class="ref-journal">Exp Cell Res. </span>2005;<span class="ref-vol">309</span>:358–69.</span> [<a href="/pubmed/16026783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16026783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.connell.2009.42">Connell JW, Lindon C, Luzio JP, Reid E. Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion. <span><span class="ref-journal">Traffic. </span>2009;<span class="ref-vol">10</span>:42–56.</span> [<a href="/pmc/articles/PMC2709849/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2709849</span></a>] [<a href="/pubmed/19000169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19000169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.da_gra_a.2019.1117">da Gra&#x000e7;a FF, de Rezende TJR, Vasconcellos LFR, Pedroso JL, Barsottini OGP, Fran&#x000e7;a MC Jr. Neuroimaging in hereditary spastic paraplegias: current use and future perspectives. <span><span class="ref-journal">Front Neurol. </span>2019;<span class="ref-vol">9</span>:1117.</span> [<a href="/pmc/articles/PMC6346681/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6346681</span></a>] [<a href="/pubmed/30713518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30713518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.de_bot.2010.1073">de Bot ST, van den Elzen RT, Mensenkamp AR, Schelhaas HJ, Willemsen MA, Knoers NV, Kremer HP, van de Warrenburg BP, Scheffer H. Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2010;<span class="ref-vol">81</span>:1073–8.</span> [<a href="/pubmed/20562464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20562464</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.depienne.2007a.281">Depienne C, Fedirko E, Forlani S, Cazeneuve C, Riba&#x000ef; P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. <span><span class="ref-journal">J Med Genet. </span>2007a;<span class="ref-vol">44</span>:281–4.</span> [<a href="/pmc/articles/PMC2598038/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2598038</span></a>] [<a href="/pubmed/17098887" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17098887</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.depienne.2007b.674">Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. <span><span class="ref-journal">Curr Opin Neurol. </span>2007b;<span class="ref-vol">20</span>:674–80.</span> [<a href="/pubmed/17992088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17992088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.duning.2010.1986">Duning T, Warnecke T, Schirmacher A, Schiffbauer H, Lohmann H, Mohammadi S, Young P, Deppe M. Specific pattern of early white-matter changes in pure hereditary spastic paraplegia. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:1986–92.</span> [<a href="/pubmed/20669295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20669295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.erichsen.2009a.1577">Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. <span><span class="ref-journal">Brain. </span>2009a;<span class="ref-vol">132</span>:1577–88.</span> [<a href="/pubmed/19339254" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19339254</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.erichsen.2009b.124">Erichsen AK, Server A, Landr&#x000f8; AI, Sandvik L, Tallaksen CME. Proton magnetic resonance spectroscopy and cognition in patients with spastin mutations. <span><span class="ref-journal">J Neurol Sci. </span>2009b;<span class="ref-vol">277</span>:124–9.</span> [<a href="/pubmed/19084842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19084842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.errico.2002.153">Errico A, Ballabio A, Rugarli EI. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:153–63.</span> [<a href="/pubmed/11809724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11809724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.fei.2011.1194">Fei QZ, Tang WG, Rong TY, Tang HD, Liu JR, Guo ZL, Fu Y, Xiao Q, Wang XJ, He SB, Cao L, Chen SD. Two novel mutations in the Spastin gene of Chinese patients with hereditary spastic paraplegia. <span><span class="ref-journal">Eur J Neurol. </span>2011;<span class="ref-vol">18</span>:1194–6.</span> [<a href="/pubmed/21834905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21834905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.fonknechten.2000.637">Fonknechten N, Mavel D, Byrne P, Davoine CS, Cruaud C, B&#x000f6;nsch D, Samson D, Coutinho P, Hutchinson M, McMonagle P, Burgunder JM, Tartaglione A, Heinzlef O, Feki I, Deufel T, Parfrey N, Brice A, Fontaine B, Prud'homme JF, Weissenbach J, D&#x000fc;rr A, Hazan J. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:637–44.</span> [<a href="/pubmed/10699187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10699187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.fourtassi.2012.558">Fourtassi M, Jacquin-Courtois S, Scheiber-Nogueira MC, Hajjioui A, Luaute J, Charvier K, Maucort-Boulch D, Rode G. Bladder dysfunction in hereditary spastic paraplegia: a clinical and urodynamic evaluation. <span><span class="ref-journal">Spinal Cord. </span>2012;<span class="ref-vol">50</span>:558–62.</span> [<a href="/pubmed/22289900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22289900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.joussain.2019.1081">Joussain C, Levy J, Charlanes A, Even A, Falcou L, Chartier Kastler E, Denys P. Urological dysfunction in patients with hereditary spastic paraplegia. <span><span class="ref-journal">Neurourol Urodyn. </span>2019;<span class="ref-vol">38</span>:1081–5.</span> [<a href="/pubmed/30848841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30848841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.kanavin.2018.58">Kanavin &#x000d8;J, Fjermestad KW. Gastrointestinal and urinary complaints in adults with hereditary spastic paraparesis. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2018;<span class="ref-vol">13</span>:58.</span> [<a href="/pmc/articles/PMC5902872/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5902872</span></a>] [<a href="/pubmed/29661209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29661209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.karczewski.2019">Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf&#x000f6;ldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv 531210. 2019. Available <a href="https://www.biorxiv.org/content/biorxiv/early/2019/01/30/531210.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. Accessed 6-11-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.karle.2013.158">Karle KN, Sch&#x000fc;le R, Klebe S, Otto S, Frischholz C, Liepelt-Scarfone I, Sch&#x000f6;ls L. Electrophysiological characterisation of motor and sensory tracts in patients with hereditary spastic paraplegia (HSP). <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:158.</span> [<a href="/pmc/articles/PMC3852552/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3852552</span></a>] [<a href="/pubmed/24107482" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24107482</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.kumar.2012.1454">Kumar KR, Sue CM, Burke D, Ng K. Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation--a neurophysiological study using excitability techniques. <span><span class="ref-journal">Clin Neurophysiol. </span>2012;<span class="ref-vol">123</span>:1454–9.</span> [<a href="/pubmed/22192498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22192498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.liao.2018.1">Liao X, Huang M, Xing W, Wu X, Liao W, Wang X, Tang B, Shen L. Resting state fMRI studies in SPG4-linked hereditary spastic paraplegia. <span><span class="ref-journal">J Neurol Sci. </span>2018;<span class="ref-vol">384</span>:1–6.</span> [<a href="/pubmed/29249364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29249364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.lindig.2015.1961">Lindig T, Bender B, Hauser TK, Mang S, Schweikardt D, Klose U, Karle KN, Sch&#x000fc;le R, Sch&#x000f6;ls L, Rattay TW. Gray and white matter alterations in hereditary spastic paraplegia type SPG4 and clinical correlations. <span><span class="ref-journal">J Neurol. </span>2015;<span class="ref-vol">262</span>:1961–71.</span> [<a href="/pubmed/26050637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26050637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.lo_giudice.2014.518">Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A. Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. <span><span class="ref-journal">Exp Neurol. </span>2014;<span class="ref-vol">261</span>:518–39.</span> [<a href="/pubmed/24954637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24954637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.loureiro.2013.481">Loureiro JL, Brand&#x000e3;o E, Ruano L, Brand&#x000e3;o AF, Lopes AM, Thieleke-Matos C, Miller-Fleming L, Cruz VT, Barbosa M, Silveira I, Stevanin G, Pinto-Basto J, Sequeiros J, Alonso I, Coutinho P. Autosomal dominant spastic paraplegias: a review of 89 families resulting from a Portuguese survey. <span><span class="ref-journal">JAMA Neurol. </span>2013;<span class="ref-vol">70</span>:481–7.</span> [<a href="/pubmed/23400676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23400676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.marras.2016.436">Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:436–57.</span> [<a href="/pubmed/27079681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27079681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.mcdermott.2006.45">McDermott CJ, Burness CE, Kirby J, Cox LE, Rao DG, Hewamadduma C, Sharrack B, Hadjivassiliou M, Chinnery PF, Dalton A, Shaw PJ, et al.  Clinical features of hereditary spastic paraplegia due to spastin mutation. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:45–51.</span> [<a href="/pubmed/16832076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16832076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.mcdermott.2003.748">McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, Bushby KM, Shaw PJ. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span>:748–59.</span> [<a href="/pubmed/14681884" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14681884</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.meijer.2002.763">Meijer IA, Hand CK, Grewal KK, Stefanelli MG, Ives EJ, Rouleau GA. A locus for autosomal dominant hereditary spastic ataxia, SAX1, maps to chromosome 12p13. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:763–9.</span> [<a href="/pmc/articles/PMC384953/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384953</span></a>] [<a href="/pubmed/11774073" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11774073</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.meyer.2005.141">Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH, Hopt A, Kopp U, Andersen P, Epplen JT, Linke P. Early-onset ALS with long-term survival associated with spastin gene mutation. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">65</span>:141–3.</span> [<a href="/pubmed/16009903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16009903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.murphy.2009.378">Murphy S, Gorman G, Beetz C, Byrne P, Dytko M, McMonagle P, Kinsella K, Farrell M, Hutchinson M. Dementia in SPG4 hereditary spastic paraplegia: clinical, genetic, and neuropathologic evidence. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:378–84.</span> [<a href="/pubmed/19652142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19652142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.orlacchio.2004.849">Orlacchio A, Kawarai T, Totaro A, Errico A, St George-Hyslop PH, Rugarli EI, Bernardi G. Hereditary spastic paraplegia: clinical genetic study of 15 families. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:849–55.</span> [<a href="/pubmed/15210521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15210521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.papadopoulos.2015.e1005149">Papadopoulos C, Orso G, Mancuso G, Herholz M, Gumeni S, Tadepalle N, J&#x000fc;ngst C, Tzschichholz A, Schauss A, H&#x000f6;ning S, Trifunovic A, Daga A, Rugarli EI. Spastin binds to lipid droplets and affects lipid metabolism. <span><span class="ref-journal">PLoS Genet. </span>2015;<span class="ref-vol">11</span>:e1005149.</span> [<a href="/pmc/articles/PMC4395272/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4395272</span></a>] [<a href="/pubmed/25875445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25875445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.park.2010.1097">Park SH, Zhu PP, Parker RL, Blackstone C. Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. <span><span class="ref-journal">J Clin Invest. </span>2010;<span class="ref-vol">120</span>:1097–110.</span> [<a href="/pmc/articles/PMC2846052/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2846052</span></a>] [<a href="/pubmed/20200447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20200447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.parodi.2018.3331">Parodi L, Fenu S, Barbier M, Banneau G, Duyckaerts C, Tezenas du Montcel S, Monin ML, Ait Said S, Guegan J, Tallaksen CME, Sablonniere B, Brice A, Stevanin G, Depienne C, Durr A, et al.  Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex. <span><span class="ref-journal">Brain. </span>2018;<span class="ref-vol">141</span>:3331–42.</span> [<a href="/pubmed/30476002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30476002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.parodi.2017.352">Parodi L, Fenu S, Stevanin G, Durr A. Hereditary spastic paraplegia: more than an upper motor neuron disease. <span><span class="ref-journal">Rev Neurol (Paris). </span>2017;<span class="ref-vol">173</span>:352–60.</span> [<a href="/pubmed/28449883" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28449883</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.patrono.2002.200">Patrono C, Casali C, Tessa A, Cricchi F, Fortini D, Carrozzo R, Siciliano G, Bertini E, Santorelli FM. Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. <span><span class="ref-journal">J Neurol. </span>2002;<span class="ref-vol">249</span>:200–5.</span> [<a href="/pubmed/11985387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11985387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.polymeris.2016.1604">Polymeris AA, Tessa A, Anagnostopoulou K, Rubegni A, Galatolo D, Dinopoulos A, Gika AD, Youroukos S, Skouteli E, Santorelli FM, Pons R. A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings. <span><span class="ref-journal">J Neurol. </span>2016;<span class="ref-vol">263</span>:1604–11.</span> [<a href="/pubmed/27260292" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27260292</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.qiang.2019.1136">Qiang L, Piermarini E, Muralidharan H, Yu W, Leo L, Hennessy LE, Fernandes S, Connors T, Yates PL, Swift M, Zholudeva LV, Lane MA, Morfini G, Alexander GM, Heiman-Patterson TD, Baas PW. Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse. <span><span class="ref-journal">Hum Mol Genet. </span>2019;<span class="ref-vol">28</span>:1136–52.</span> [<a href="/pmc/articles/PMC6423423/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6423423</span></a>] [<a href="/pubmed/30520996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30520996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.reid.2005.19">Reid E, Connell J, Edwards TL, Duley S, Brown SE, Sanderson CM. The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:19–38.</span> [<a href="/pubmed/15537668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15537668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.rezende.2015.e0117666">Rezende TJ, de Albuquerque M, Lamas GM, Martinez AR, Campos BM, Casseb RF, Silva CB, Branco LM, D'Abreu A, Lopes-Cendes I, Cendes F, Fran&#x000e7;a MC Jr. Multimodal MRI-based study in patients with SPG4 mutations. <span><span class="ref-journal">PLoS One. </span>2015;<span class="ref-vol">10</span>:e0117666.</span> [<a href="/pmc/articles/PMC4320056/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4320056</span></a>] [<a href="/pubmed/25658484" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25658484</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.richards.2015.405">Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, et al.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. <span><span class="ref-journal">Genet Med. </span>2015;<span class="ref-vol">17</span>:405–24.</span> [<a href="/pmc/articles/PMC4544753/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4544753</span></a>] [<a href="/pubmed/25741868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25741868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.ruano.2014.174">Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. <span><span class="ref-journal">Neuroepidemiology. </span>2014;<span class="ref-vol">42</span>:174–83.</span> [<a href="/pubmed/24603320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24603320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.rucco.2019.979">Rucco R, Liparoti M, Jacini F, Baselice F, Antenora A, De Michele G, Criscuolo C, Vettoliere A, Mandolesi L, Sorrentino G, Sorrentino P. Mutations in the SPAST gene causing hereditary spastic paraplegia are related to global topological alterations in brain functional networks. <span><span class="ref-journal">Neurol Sci. </span>2019;<span class="ref-vol">40</span>:979–84.</span> [<a href="/pmc/articles/PMC6478644/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6478644</span></a>] [<a href="/pubmed/30737580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30737580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.scheuer.2007.663">Scheuer KH, Svenstrup K, Jennum P, Rogvi-Hansen B, Werdelin L, Fenger K, Nielsen JE. Double blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia. <span><span class="ref-journal">Eur J Neurol. </span>2007;<span class="ref-vol">14</span>:663–6.</span> [<a href="/pubmed/17539946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17539946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.schickel.2007.1322">Schickel J, Pamminger T, Ehrsam A, M&#x000fc;nch S, Huang X, Klopstock T, Kurlemann G, Hemmerich P, Dubiel W, Deufel T, Beetz C. Isoform-specific increase of spastin stability by N-terminal missense variants including intragenic modifiers of SPG4 hereditary spastic paraplegia. <span><span class="ref-journal">Eur J Neurol. </span>2007;<span class="ref-vol">14</span>:1322–8.</span> [<a href="/pubmed/17916079" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17916079</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.schneider.2019.207">Schneider SA, Beckinger VE, M&#x000f6;ller B, Kn&#x000fc;pfer S, Hamann M, Deuschl G. Urinary symptoms, quality of life, and patient satisfaction in genetic and sporadic hereditary spastic paraplegia. <span><span class="ref-journal">J Neurol. </span>2019;<span class="ref-vol">266</span>:207–11.</span> [<a href="/pubmed/30467602" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30467602</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.servelhere.2018.183">Servelhere KR, Faber I, Martinez A, Nickel R, Moro A, Germiniani FMB, Moscovich M, Blume TR, Munhoz RP, Teive HAG, Fran&#x000e7;a MC Jr. Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations. <span><span class="ref-journal">Arq Neuropsiquiatr. </span>2018;<span class="ref-vol">76</span>:183–8.</span> [<a href="/pubmed/29809239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29809239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.servelhere.2016.408">Servelhere KR, Faber I, Saute JA, Moscovich M, D'Abreu A, Jardim LB, Teive HA, Lopes-Cendes I, Franca MC Jr. Non-motor symptoms in patients with hereditary spastic paraplegia caused by SPG4 mutations. <span><span class="ref-journal">Eur J Neurol. </span>2016;<span class="ref-vol">23</span>:408–11.</span> [<a href="/pubmed/26806216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26806216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.shoukier.2009.187">Shoukier M, Neesen J, Sauter SM, Argyriou L, Doerwald N, Pantakani DV, Mannan AU. Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:187–94.</span> [<a href="/pmc/articles/PMC2986068/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986068</span></a>] [<a href="/pubmed/18701882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18701882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.solowska.2014.1856">Solowska JM, D'Rozario M, Jean DC, Davidson MW, Marenda DR, Baas PW. Pathogenic mutation of spastin has gain-of-function effects on microtubule dynamics. <span><span class="ref-journal">J Neurosci. </span>2014;<span class="ref-vol">34</span>:1856–67.</span> [<a href="/pmc/articles/PMC3905148/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3905148</span></a>] [<a href="/pubmed/24478365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24478365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.solowska.2010.2767">Solowska JM, Garbern JY, Baas PW. Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:2767–79.</span> [<a href="/pmc/articles/PMC2893808/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2893808</span></a>] [<a href="/pubmed/20430936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20430936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.sperfeld.2007.31">Sperfeld AD, Unrath A, Kassubek J. Restless legs syndrome in hereditary spastic paraparesis. <span><span class="ref-journal">Eur Neurol. </span>2007;<span class="ref-vol">57</span>:31–5.</span> [<a href="/pubmed/17108692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17108692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.svenson.2004.157">Svenson IK, Kloos MT, Gaskell PC, Nance MA, Garbern JY, Hisanaga S, Pericak-Vance MA, Ashley-Koch AE, Marchuk DA. Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. <span><span class="ref-journal">Neurogenetics. </span>2004;<span class="ref-vol">5</span>:157–64.</span> [<a href="/pubmed/15248095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15248095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.svenstrup.2009.90">Svenstrup K, Bross P, Koefoed P, Hjermind LE, Eiberg H, Born AP, Vissing J, Gyllenborg J, N&#x000f8;rrem&#x000f8;lle A, Hasholt L, Nielsen JE. Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia. <span><span class="ref-journal">J Neurol Sci. </span>2009;<span class="ref-vol">284</span>:90–5.</span> [<a href="/pubmed/19423133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19423133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.takiyama.2010.931">Takiyama Y, Ishiura H, Shimazaki H, Namekawa M, Takahashi Y, Goto J, Tsuji S, Nishizawa M. Japan spastic paraplegia research consortium (JASPAC). <span><span class="ref-journal">Rinsho Shinkeigaku. </span>2010;<span class="ref-vol">50</span>:931–4.</span> [<a href="/pubmed/21921516" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21921516</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.tallaksen.2003.1113">Tallaksen CM, Guichart-Gomez E, Verpillat P, Hahn-Barma V, Ruberg M, Fontaine B, Brice A, Dubois B, Durr A. Subtle cognitive impairment but no dementia in patients with spastin mutations. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1113–8.</span> [<a href="/pubmed/12925368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12925368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.wharton.2003.1166">Wharton SB, McDermott CJ, Grierson AJ, Wood JD, Gelsthorpe C, Ince PG, Shaw PJ. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2003;<span class="ref-vol">62</span>:1166–77.</span> [<a href="/pubmed/14656074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14656074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg4.REF.white.2007.995">White SR, Evans KJ, Lary J, Cole JL, Lauring B. Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing. <span><span class="ref-journal">J Cell Biol. </span>2007;<span class="ref-vol">176</span>:995–1005.</span> [<a href="/pmc/articles/PMC2064084/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2064084</span></a>] [<a href="/pubmed/17389232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17389232</span></a>]</div></li></ul></div></div><div id="spg4.Chapter_Notes"><h2 id="_spg4_Chapter_Notes_">Chapter Notes</h2><div id="spg4.Author_History"><h3>Author History</h3><p>Christel Depienne, PhD; H&#x000f4;pital Piti&#x000e9; Salp&#x000ea;tri&#x000e8;re (2003-2019)<br />Alexandra Durr, MD, PhD (2003-present)<br />Livia Parodi, PhD (2019-present)<br />Siri Lynne Rydning, MD (2019-present)<br />Chantal Tallaksen, MD, PhD (2003-present)</p></div><div id="spg4.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 June 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 August 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 June 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 April 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> clinically available</div></li><li class="half_rhythm"><div>10 August 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 April 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>25 September 2002 (ct) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1160</span><span class="label">PMID: <a href="/pubmed/20301339" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301339</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spg3a/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spg7/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1160&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1160/?report=reader">PubReader</a></li><li><a href="/books/NBK1160/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1160" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1160" style="display:none" title="Cite this Page"><div class="bk_tt">Parodi L, Rydning SL, Tallaksen C, et al. Spastic Paraplegia 4. 2003 Apr 17 [Updated 2019 Jun 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1160/pdf/Bookshelf_NBK1160.pdf">PDF version of this page</a> (478K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#spg4.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#spg4.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#spg4.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#spg4.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#spg4.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#spg4.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#spg4.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#spg4.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#spg4.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#spg4.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#spg4.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6683[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPAST</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1490342" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1490342" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1490342" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1490342" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20862796" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 3A</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 3A<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hedera P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301389" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 11</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 11<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stevanin G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26208798" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutational spectrum of the SPAST and ATL1 genes in Korean patients with hereditary spastic paraplegia.</a><span class="source">[J Neurol Sci. 2015]</span><div class="brieflinkpop offscreen_noflow">Mutational spectrum of the SPAST and ATL1 genes in Korean patients with hereditary spastic paraplegia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Park H, Kang SH, Park S, Kim SY, Seo SH, Lee SJ, Lee JA, Cho SI, Sung JJ, Lee KW, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2015 Oct 15; 357(1-2):167-72. Epub 2015 Jul 17.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19423133" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia.</a><span class="source">[J Neurol Sci. 2009]</span><div class="brieflinkpop offscreen_noflow">Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Svenstrup K, Bross P, Koefoed P, Hjermind LE, Eiberg H, Born AP, Vissing J, Gyllenborg J, Nørremølle A, Hasholt L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2009 Sep 15; 284(1-2):90-5. Epub 2009 May 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25315759" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A complex form of hereditary spastic paraplegia in three siblings due to somatic mosaicism for a novel SPAST mutation in the mother.</a><span class="source">[J Neurol Sci. 2014]</span><div class="brieflinkpop offscreen_noflow">A complex form of hereditary spastic paraplegia in three siblings due to somatic mosaicism for a novel SPAST mutation in the mother.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Aulitzky A, Friedrich K, Gläser D, Gastl R, Kubisch C, Ludolph AC, Volk AE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2014 Dec 15; 347(1-2):352-5. Epub 2014 Oct 2.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301339" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301339" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0411afdde08911699f613e">Spastic Paraplegia 4 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spastic Paraplegia 4 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:49:36-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE889FC9E03F6AB1000000000A490390&amp;ncbi_session=CE889FC9E0411AF1_2633SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1160%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1160&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1160/&amp;ncbi_pagename=Spastic Paraplegia 4 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE889FC9E0411AF1_2633SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>